1Mccullough PA. Clinical applications of B - type natriuretic peptide levels in the care of cardiovascular patients [ J ]. Minerva Cardioangiol,2004,52( 3 ) :479.
2Sudoh T,Kangawa K,Minamino N,et al. A natriuretic peptide in porcine brain[J]. Nature, 1998,332( 1 ) :78.
4Connel JM,Davies E. The new biology of aldosterone[J]. J Endocrinol,2005,186 ( 1 ) :1.
5Abraham WT, Lowes BD, Ferguson DA, et al. Systemic hemodynamic,neurohormonal, and renal excretory effects of a steady state infusion of human brain natriuretic peptide in patients with decompensated chronic heart failure[ J ]. Card Fail, 1998,4( 1 ) :37.
6Qiu C,Williams MA, Vadachkoria S,et al. Increased maternal plasma leptin in early pregnancy and risk of gestational diabetesmellitus[ J ]. Obstet Gynecol,2004, 103 (3) :519.
8Roger M ,Thierry H. Sustainded hemodynamic effects of infusion of nesinitide ( human B - type natriuretics peptide) in heart failure [ J]. JACC, 1999,34 ( 1 ) :155.
6Eagle KA, Berger PB. ACC/AHA guideline update for preoperative cardiovascular evaluation for noncardiac cardiac surgery executive summary[J]. Circulation, 2002,105 (10) : 1257-- 1267.
7Weber M, Hamm C. Role of B-type natriuretic peptide and NT-pro BNP in clinical routine[J]. Heart, 2006, 92(8): 843--849.
8Dernellis J, Panaretou M. Assessment of cardiac risk before noncardiac surgery: brain natriuretic peptide in 1590 patients[J]. Heart, 2006, 92:1645--1650.
9Maisel AS, Koon J, Krishnaswamy P, et al. Utility of B-type natri- uretic peptide as a rapid9 point of care test for screening patients undergoing echocardiography to determine left ventricular dysfunction [J].Am Heart J, 2001, 141:367--374.
10Maisel A. B-type natriuretic peptide levels: A potential novel "white count" for congestive heart failure[J]. J Card Fail, 2001,7 : 183-- 193.
